121 related articles for article (PubMed ID: 10235486)
1. Production and characterization of an anti-(MUC1 mucin) recombinant diabody.
Denton G; Brady K; Lo BK; Murray A; Graves CR; Hughes OD; Tendler SJ; Laughton CA; Price MR
Cancer Immunol Immunother; 1999 Apr; 48(1):29-38. PubMed ID: 10235486
[TBL] [Abstract][Full Text] [Related]
2. Production and characterization of a recombinant anti-MUC1 scFv reactive with human carcinomas.
Denton G; Sekowski M; Spencer DI; Hughes OD; Murray A; Denley H; Tendler SJ; Price MR
Br J Cancer; 1997; 76(5):614-21. PubMed ID: 9303360
[TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of recombinant single chain Fv antibody that recognizes platelet glycoprotein Ibalpha.
Dai K; Zhu H; Ruan C
Thromb Res; 2003 Jan; 109(2-3):137-44. PubMed ID: 12706643
[TBL] [Abstract][Full Text] [Related]
4. Generation of a single-chain Fv fragment for the monitoring of deoxycholic acid residues anchored on endogenous proteins.
Kobayashi N; Ohtoyo M; Wada E; Kato Y; Mano N; Goto J
Steroids; 2005 Apr; 70(4):285-94. PubMed ID: 15784283
[TBL] [Abstract][Full Text] [Related]
5. Effect of domain order on the activity of bacterially produced bispecific single-chain Fv antibodies.
Kipriyanov SM; Moldenhauer G; Braunagel M; Reusch U; Cochlovius B; Le Gall F; Kouprianova OA; Von der Lieth CW; Little M
J Mol Biol; 2003 Jun; 330(1):99-111. PubMed ID: 12818205
[TBL] [Abstract][Full Text] [Related]
6. Efficient construction of a diabody using a refolding system: anti-carcinoembryonic antigen recombinant antibody fragment.
Asano R; Kudo T; Nishimura Y; Makabe K; Hayashi H; Suzuki M; Tsumoto K; Kumagai I
J Biochem; 2002 Dec; 132(6):903-9. PubMed ID: 12473192
[TBL] [Abstract][Full Text] [Related]
7. Functional construction of the anti-mucin core protein (MUC1) antibody MUSE11 variable regions in a bacterial expression system.
Asano R; Takemura S; Tsumoto K; Sakurai N; Teramae A; Ebara S; Katayose Y; Shinoda M; Suzuki M; Imai K; Matsuno S; Kudo T; Kumagai I
J Biochem; 2000 Apr; 127(4):673-9. PubMed ID: 10739961
[TBL] [Abstract][Full Text] [Related]
8. Recombinant single-chain Fv fragments carrying C-terminal cysteine residues: production of bivalent and biotinylated miniantibodies.
Kipriyanov SM; Dübel S; Breitling F; Kontermann RE; Little M
Mol Immunol; 1994 Oct; 31(14):1047-58. PubMed ID: 7935496
[TBL] [Abstract][Full Text] [Related]
9. Production of a single-chain fragment of the murine anti-idiotypic antibody ACA125 as phage-displayed and soluble antibody by recombinant phage antibody technique.
Schlebusch H; Reinartz S; Kaiser R; Grünn U; Wagner U
Hybridoma; 1997 Feb; 16(1):47-52. PubMed ID: 9085128
[TBL] [Abstract][Full Text] [Related]
10. Construction and characterization of a bispecific diabody for retargeting T cells to human carcinomas.
Helfrich W; Kroesen BJ; Roovers RC; Westers L; Molema G; Hoogenboom HR; de Leij L
Int J Cancer; 1998 Apr; 76(2):232-9. PubMed ID: 9537586
[TBL] [Abstract][Full Text] [Related]
11. Construction, expression, purification, refold and activity assay of a specific scFv fragment against foot and mouth disease virus.
ShengFeng C; Ping L; Tao S; Xin W; GuoFeng W
Vet Res Commun; 2003 Apr; 27(3):243-56. PubMed ID: 12777098
[TBL] [Abstract][Full Text] [Related]
12. Production and characterization of an anti-idiotypic single chain Fv that recognizes an anti-DNA antibody.
Kwon MH; Lee MS; Kim KH; Park S; Shin HJ; Jang YJ; Kim HI
Immunol Invest; 2002; 31(3-4):205-18. PubMed ID: 12472180
[TBL] [Abstract][Full Text] [Related]
13. Anti-HLA-DR/anti-DOTA diabody construction in a modular gene design platform: bispecific antibodies for pretargeted radioimmunotherapy.
DeNardo DG; Xiong CY; Shi XB; DeNardo GL; DeNardo SJ
Cancer Biother Radiopharm; 2001 Dec; 16(6):525-35. PubMed ID: 11789029
[TBL] [Abstract][Full Text] [Related]
14. Construction of mono- and bivalent human single-chain Fv fragments against the D antigen in the Rh blood group: multimerization effect on cell agglutination and application to blood typing.
Furuta M; Uchikawa M; Ueda Y; Yabe T; Taima T; Tsumoto K; Kojima S; Juji T; Kumagai I
Protein Eng; 1998 Mar; 11(3):233-41. PubMed ID: 9613848
[TBL] [Abstract][Full Text] [Related]
15. Construction and expression of a single chain Fv fragment against pharmacologically active paeoniflorin in Escherichia coli, and its potential use in an enzyme-linked immunosorbent assay.
Lu Z; Masaki T; Shoyama Y; Tanaka H
Planta Med; 2006 Feb; 72(2):151-5. PubMed ID: 16491451
[TBL] [Abstract][Full Text] [Related]
16. Bacterial expression of a single-chain antibody fragment (SCFV) that neutralizes the biological activity of human interferon-gamma.
Froyen G; Ronsse I; Billiau A
Mol Immunol; 1993 Jun; 30(9):805-12. PubMed ID: 8321246
[TBL] [Abstract][Full Text] [Related]
17. Anti-estradiol-17beta single-chain Fv fragments: Generation, characterization, gene randomization, and optimized phage display.
Kobayashi N; Kato Y; Oyama H; Taga S; Niwa T; Sun P; Ohtoyo M; Goto J
Steroids; 2008 Dec; 73(14):1485-99. PubMed ID: 18824188
[TBL] [Abstract][Full Text] [Related]
18. Production of a single-chain variable fragment antibody recognizing type III mutant epidermal growth factor receptor.
Nakayashiki N; Yoshikawa K; Nakamura K; Hanai N; Okamoto K; Okamoto S; Mizuno M; Wakabayashi T; Saga S; Yoshida J; Takahashi T
Jpn J Cancer Res; 2000 Oct; 91(10):1035-43. PubMed ID: 11050475
[TBL] [Abstract][Full Text] [Related]
19. Functional human monoclonal antibodies of all isotypes constructed from phage display library-derived single-chain Fv antibody fragments.
Boel E; Verlaan S; Poppelier MJ; Westerdaal NA; Van Strijp JA; Logtenberg T
J Immunol Methods; 2000 May; 239(1-2):153-66. PubMed ID: 10821956
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of a recombinant Fv fragment by base-loop interconnection and V(H)-V(L) permutation.
Brinkmann U; Di Carlo A; Vasmatzis G; Kurochkina N; Beers R; Lee B; Pastan I
J Mol Biol; 1997 Apr; 268(1):107-17. PubMed ID: 9149145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
